Healthcare services company Chemed Corporation (NYSE:CHE) reported Q1 CY2026 results , with sales up 1.6% year on year to ...

Chemed Corp (CHE) reports robust growth in VITAS admissions and revenue, while Roto-Rooter faces headwinds from weather disruptions and increased marketing costs.

Chemed’s first quarter results were well received by the market, reflecting stronger-than-expected performance at its VITAS ...

Strong VITAS Performance Re-purchase of 500,000 Shares in the Quarter Two Roto-Rooter Franchises Purchased for $20.6 Million ...